Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

BUY
$73.94 - $80.67 $443 - $484
6 Added 1.06%
573 $42,000
Q2 2023

Jul 13, 2023

BUY
$76.01 - $86.7 $380 - $433
5 Added 0.89%
567 $43,000
Q1 2023

Aug 21, 2023

BUY
$77.31 - $88.08 $1,236 - $1,409
16 Added 2.93%
562 $46,000
Q1 2023

Apr 28, 2023

BUY
$77.31 - $88.08 $386 - $440
5 Added 0.9%
562 $47,000
Q4 2022

Aug 21, 2023

BUY
$62.32 - $89.47 $311 - $447
5 Added 0.91%
557 $47,000
Q4 2022

Jan 20, 2023

BUY
$62.32 - $89.47 $311 - $447
5 Added 0.91%
557 $48,000
Q3 2022

Aug 21, 2023

SELL
$59.54 - $68.01 $893 - $1,020
-15 Reduced 2.65%
552 $34,000
Q3 2022

Oct 24, 2022

BUY
$59.54 - $68.01 $357 - $408
6 Added 1.1%
552 $34,000
Q2 2022

Aug 21, 2023

BUY
$57.72 - $65.01 $404 - $455
7 Added 1.3%
546 $33,000
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $404 - $455
7 Added 1.3%
546 $34,000
Q1 2022

Aug 21, 2023

SELL
$57.92 - $72.58 $1,621 - $2,032
-28 Reduced 4.94%
539 $32,000
Q1 2022

Apr 22, 2022

BUY
$57.92 - $72.58 $31,218 - $39,120
539 New
539 $32,000
Q4 2021

Sep 11, 2023

BUY
$64.88 - $73.64 $324 - $368
5 Added 0.95%
533 $38,000
Q4 2021

Feb 17, 2023

BUY
$64.88 - $73.64 $324 - $368
5 Added 0.95%
533 $39,000
Q3 2021

Sep 11, 2023

BUY
$67.69 - $73.03 $406 - $438
6 Added 1.15%
528 $36,000
Q3 2021

Feb 17, 2023

BUY
$67.69 - $73.03 $406 - $438
6 Added 1.15%
528 $37,000
Q2 2021

Sep 11, 2023

BUY
$63.47 - $69.35 $317 - $346
5 Added 0.97%
522 $35,000
Q2 2021

Feb 17, 2023

BUY
$63.47 - $69.35 $317 - $346
5 Added 0.97%
522 $36,000
Q1 2021

Sep 11, 2023

SELL
$60.0 - $68.46 $3,000 - $3,422
-50 Reduced 8.82%
517 $33,000
Q1 2021

Feb 17, 2023

BUY
$60.0 - $68.46 $360 - $410
6 Added 1.17%
517 $33,000
Q4 2020

Sep 05, 2023

BUY
$56.65 - $64.55 $339 - $387
6 Added 1.19%
511 $29,000
Q4 2020

Feb 17, 2023

BUY
$56.65 - $64.55 $339 - $387
6 Added 1.19%
511 $30,000
Q3 2020

Sep 05, 2023

BUY
$62.1 - $78.08 $310 - $390
5 Added 1.0%
505 $31,000
Q3 2020

Feb 17, 2023

BUY
$62.1 - $78.08 $310 - $390
5 Added 1.0%
505 $32,000
Q1 2020

Sep 05, 2023

SELL
$62.63 - $80.22 $4,196 - $5,374
-67 Reduced 11.82%
500 $37,000
Q1 2020

Feb 17, 2023

SELL
$62.63 - $80.22 $3,569 - $4,572
-57 Reduced 10.23%
500 $37,000
Q1 2019

Sep 01, 2023

SELL
$62.53 - $70.05 $4,189 - $4,693
-67 Reduced 11.82%
500 $32,000
Q1 2019

Feb 13, 2023

SELL
$62.53 - $70.05 $3,564 - $3,992
-57 Reduced 10.23%
500 $33,000
Q4 2018

Feb 09, 2023

SELL
$60.54 - $79.0 $3,450 - $4,503
-57 Reduced 10.23%
500 $31,000
Q1 2018

Aug 29, 2023

SELL
$72.84 - $88.8 $4,880 - $5,949
-67 Reduced 11.82%
500 $37.7 Million
Q2 2017

Aug 29, 2023

SELL
N/A
-67 Reduced 11.82%
500 $35.4 Million
Q1 2017

Aug 29, 2023

SELL
N/A
-67 Reduced 11.82%
500 $0
Q1 2017

Feb 09, 2023

SELL
N/A
-57
500 $34,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Artemis Wealth Advisors, LLC Portfolio

Follow Artemis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.